Status:
TERMINATED
Fetal Genome Profiling Via Trophoblast Cells
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Fetal Growth Retardation
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
The objective of this study is to utilize trophoblast cells accumulating in the endocervical canal at the beginning of pregnancy for non-invasive prenatal testing. If we are able to validate that trop...
Detailed Description
The primary purpose of the study is to validate trophoblast retrieval and isolation from the cervix (TRIC) as a means of reliable non invasive prenatal genetic diagnosis (for both chromosomal abnormal...
Eligibility Criteria
Inclusion
- Women 18 to 45 who achieve a pregnancy during study time period.
- If pregnancy result in miscarriage, cytogenetic testing must be completed on the product of conception.
Exclusion
- Women whose cervical sample collection containing inadequate number of trophoblast cells for analysis.
Key Trial Info
Start Date :
July 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 2 2023
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03832634
Start Date
July 2 2020
End Date
February 2 2023
Last Update
August 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10021